Butterfly Network (BFLY) Non-Current Deffered Revenue (2020 - 2026)
Butterfly Network (BFLY) reported Non-Current Deffered Revenue of $9.6 million for Q1 2026, up 26.74% on a YoY basis from $7.6 million in Q1 2025, and up 2.56% sequentially from $9.4 million in Q4 2025.
Butterfly Network (BFLY) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Non-Current Deffered Revenue data on file, last reported at $9.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deffered Revenue rose 26.74% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2026 stood at $9.6 million (up 26.74% YoY), and the FY2025 full-year result was $9.4 million, up 28.38% from the prior year.
- Non-Current Deffered Revenue climbed to $9.6 million in Q1 2026, from $9.4 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $9.6 million in Q1 2026 to a low of $4.3 million in Q1 2023.
- A 5-year average of $6.9 million and a median of $7.2 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue sank 30.74% in 2023 and jumped 66.14% in 2024, its largest moves.
- Tracing BFLY's Non-Current Deffered Revenue over 5 years: stood at $5.0 million in 2022, then soared by 49.16% to $7.4 million in 2023, then slipped by 1.07% to $7.3 million in 2024, then gained by 28.38% to $9.4 million in 2025, then rose by 2.56% to $9.6 million in 2026.
- Business Quant data shows BFLY's Non-Current Deffered Revenue at $9.6 million in Q1 2026, $9.4 million in Q4 2025, and $7.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 512.79 Mn |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.63 Mn |
| Dec 31, 2025 | 9.39 Mn |
| Sep 30, 2025 | 7.91 Mn |
| Jun 30, 2025 | 7.23 Mn |
| Mar 31, 2025 | 7.60 Mn |
| Dec 31, 2024 | 7.32 Mn |
| Sep 30, 2024 | 7.04 Mn |
| Jun 30, 2024 | 7.36 Mn |
| Mar 31, 2024 | 7.22 Mn |
| Dec 31, 2023 | 7.39 Mn |
| Sep 30, 2023 | 5.27 Mn |
| Jun 30, 2023 | 6.03 Mn |
| Mar 31, 2023 | 4.34 Mn |
| Dec 31, 2022 | 4.96 Mn |
| Sep 30, 2022 | 5.59 Mn |
| Jun 30, 2022 | 6.95 Mn |
| Mar 31, 2022 | 6.27 Mn |
| Dec 31, 2021 | 5.48 Mn |
| Sep 30, 2021 | 4.88 Mn |
| Jun 30, 2021 | 4.84 Mn |